198 related articles for article (PubMed ID: 28591149)
1. Greater HbA1c variability is associated with increased cardiovascular events in type 2 diabetes patients with preserved renal function, but not in moderate to advanced chronic kidney disease.
Lee MY; Hsiao PJ; Huang YT; Huang JC; Hsu WH; Chen SC; Shin SJ
PLoS One; 2017; 12(6):e0178319. PubMed ID: 28591149
[TBL] [Abstract][Full Text] [Related]
2. Hemoglobin A1c variability as an independent correlate of cardiovascular disease in patients with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study.
Penno G; Solini A; Zoppini G; Orsi E; Fondelli C; Zerbini G; Morano S; Cavalot F; Lamacchia O; Trevisan R; Vedovato M; Pugliese G;
Cardiovasc Diabetol; 2013 Jul; 12():98. PubMed ID: 23829205
[TBL] [Abstract][Full Text] [Related]
3. Risk association of HbA1c variability with chronic kidney disease and cardiovascular disease in type 2 diabetes: prospective analysis of the Hong Kong Diabetes Registry.
Luk AO; Ma RC; Lau ES; Yang X; Lau WW; Yu LW; Chow FC; Chan JC; So WY
Diabetes Metab Res Rev; 2013 Jul; 29(5):384-90. PubMed ID: 23463747
[TBL] [Abstract][Full Text] [Related]
4. Association of HbA
Lee MY; Huang JC; Chen SC; Chiou HC; Wu PY
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567403
[TBL] [Abstract][Full Text] [Related]
5. Dynamic Changes in Renal Function Are Associated With Major Cardiovascular Events in Patients With Type 2 Diabetes.
Ragot S; Saulnier PJ; Velho G; Gand E; de Hauteclocque A; Slaoui Y; Potier L; Sosner P; Halimi JM; Zaoui P; Rigalleau V; Fumeron F; Roussel R; Marre M; Hadjadj S;
Diabetes Care; 2016 Jul; 39(7):1259-66. PubMed ID: 27222502
[TBL] [Abstract][Full Text] [Related]
6. Variability in HbA1c, blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes.
Ceriello A; De Cosmo S; Rossi MC; Lucisano G; Genovese S; Pontremoli R; Fioretto P; Giorda C; Pacilli A; Viazzi F; Russo G; Nicolucci A;
Diabetes Obes Metab; 2017 Nov; 19(11):1570-1578. PubMed ID: 28432733
[TBL] [Abstract][Full Text] [Related]
7. Glycemic control patterns and kidney disease progression among primary care patients with diabetes mellitus.
Cummings DM; Larsen LC; Doherty L; Lea CS; Holbert D
J Am Board Fam Med; 2011; 24(4):391-8. PubMed ID: 21737763
[TBL] [Abstract][Full Text] [Related]
8. Glycated hemoglobin variability and the risk of cardiovascular events in patients with prediabetes and type 2 diabetes mellitus: A post-hoc analysis of a prospective and multicenter study.
Manosroi W; Phimphilai M; Waisayanand N; Buranapin S; Deerochanawong C; Gunaparn S; Phrommintikul A; Wongcharoen W;
J Diabetes Investig; 2023 Dec; 14(12):1391-1400. PubMed ID: 37610280
[TBL] [Abstract][Full Text] [Related]
9. Effect of renal function on serum concentration of 1,5-anhydroglucitol in type 2 diabetic patients in chronic kidney disease stages I-III: A comparative study with HbA1c and glycated albumin.
Hasslacher C; Kulozik F
J Diabetes; 2016 Sep; 8(5):712-9. PubMed ID: 26615054
[TBL] [Abstract][Full Text] [Related]
10. Visit-to-Visit HbA
Li S; Nemeth I; Donnelly L; Hapca S; Zhou K; Pearson ER
Diabetes Care; 2020 Feb; 43(2):426-432. PubMed ID: 31727686
[TBL] [Abstract][Full Text] [Related]
11. GREATER LOW-DENSITY LIPOPROTEIN CHOLESTEROL VARIABILITY INCREASES THE RISK OF CARDIOVASCULAR EVENTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS.
Hsu WH; Lai CW; Chen SC; Chiou HC; Hsiao PJ; Shin SJ; Lee MY
Endocr Pract; 2019 Sep; 25(9):918-925. PubMed ID: 31070951
[No Abstract] [Full Text] [Related]
12. Haemoglobin A1c variability is a strong, independent predictor of all-cause mortality in patients with type 2 diabetes.
Orsi E; Solini A; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Gruden G; Morano S; Nicolucci A; Penno G; Pugliese G;
Diabetes Obes Metab; 2018 Aug; 20(8):1885-1893. PubMed ID: 29582548
[TBL] [Abstract][Full Text] [Related]
13. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA
Rosenstock J; Perkovic V; Alexander JH; Cooper ME; Marx N; Pencina MJ; Toto RD; Wanner C; Zinman B; Baanstra D; Pfarr E; Mattheus M; Broedl UC; Woerle HJ; George JT; von Eynatten M; McGuire DK;
Cardiovasc Diabetol; 2018 Mar; 17(1):39. PubMed ID: 29540217
[TBL] [Abstract][Full Text] [Related]
14. Chronic kidney disease categories and renal-cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25).
Yokoyama H; Araki S; Haneda M; Matsushima M; Kawai K; Hirao K; Oishi M; Sugimoto K; Sone H; Maegawa H; Kashiwagi A;
Diabetologia; 2012 Jul; 55(7):1911-8. PubMed ID: 22476921
[TBL] [Abstract][Full Text] [Related]
15. Fluctuation between fasting and 2-H postload glucose state is associated with chronic kidney disease in previously diagnosed type 2 diabetes patients with HbA1c ≥ 7%.
Wang C; Song J; Ma Z; Yang W; Li C; Zhang X; Hou X; Sun Y; Lin P; Liang K; Gong L; Wang M; Liu F; Li W; Yan F; Yang J; Wang L; Tian M; Liu J; Zhao R; Chen L
PLoS One; 2014; 9(7):e102941. PubMed ID: 25047354
[TBL] [Abstract][Full Text] [Related]
16. Carotid Intima-Media Thickness and Visit-to-Visit HbA1c Variability Predict Progression of Chronic Kidney Disease in Type 2 Diabetic Patients with Preserved Kidney Function.
Takenouchi A; Tsuboi A; Kurata M; Fukuo K; Kazumi T
J Diabetes Res; 2016; 2016():3295747. PubMed ID: 28090540
[No Abstract] [Full Text] [Related]
17. Excessive visit-to-visit glycemic variability independently deteriorates the progression of endothelial and renal dysfunction in patients with type 2 diabetes mellitus.
Wei F; Sun X; Zhao Y; Zhang H; Diao Y; Liu Z
BMC Nephrol; 2016 Jul; 17(1):67. PubMed ID: 27386849
[TBL] [Abstract][Full Text] [Related]
18. HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study.
Penno G; Solini A; Bonora E; Fondelli C; Orsi E; Zerbini G; Morano S; Cavalot F; Lamacchia O; Laviola L; Nicolucci A; Pugliese G;
Diabetes Care; 2013 Aug; 36(8):2301-10. PubMed ID: 23491522
[TBL] [Abstract][Full Text] [Related]
19. Impact of Baseline Glycemic Control on Residual Cardiovascular Risk in Patients With Diabetes Mellitus and High-Risk Vascular Disease Treated With Statin Therapy.
Menon V; Kumar A; Patel DR; John JS; Wolski KE; McErlean E; Riesmeyer JS; Weerakkody G; Ruotolo G; Cremer PC; Nicholls SJ; Lincoff AM; Nissen SE
J Am Heart Assoc; 2020 Jan; 9(1):e014328. PubMed ID: 31852422
[TBL] [Abstract][Full Text] [Related]
20. Use of estimated glomerular filtration rate to predict incident chronic kidney disease in patients at risk of cardiovascular disease: a retrospective study.
Al-Shamsi S; Oulhaj A; Regmi D; Govender RD
BMC Nephrol; 2019 Aug; 20(1):325. PubMed ID: 31429712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
